Plasma neuropeptide Y levels were significantly elevated in acute myocardial infarction patients compared to controls, suggesting NPY as a potential biomarker for heart attack diagnosis and prognosis.
NPY elevated in MIPlasma neuropeptide Y significantly higher in heart attack patients, correlating with cardiac damage severity
What the researchers found
Plasma NPY was significantly elevated in acute myocardial infarction patients vs controls, with levels correlating with cardiac damage severity.
Why it matters
Rapid and accurate heart attack diagnosis saves lives. If NPY provides complementary diagnostic information beyond traditional markers like troponin, it could improve early detection and risk stratification.
The numbers in context
128 acute MI cases and 62 controls; cases sub-grouped into SYNTAX ≤22, 23-32, and ≥33 categories.
How the study worked
Case-control study comparing plasma NPY levels between acute MI patients and matched healthy controls. Assessed correlation with cardiac injury markers and clinical outcomes.
Who was studied
128 acute myocardial infarction patients and 62 healthy controls
What this study cannot tell us
Case-control design cannot prove causation. NPY elevation could reflect general stress rather than specific cardiac damage. Small sample size typical of biomarker discovery studies. Clinical utility requires validation in larger prospective studies.
How to read the evidence
Moderate evidence: well-designed case-control study with significant findings, but requires validation in larger prospective cohorts.
When this study was published
Published in 2024. Adds to evidence for NPY as a cardiovascular biomarker.
The bigger picture
NPY reflects sympathetic nervous system activation during cardiac stress. Its elevation during heart attacks connects the neuro-peptide system to acute cardiovascular events, potentially informing both diagnosis and understanding of how the nervous system contributes to cardiac damage.
Questions still open
- Does NPY add diagnostic value beyond troponin for early heart attack detection?
- Could NPY levels predict heart attack outcomes like mortality or heart failure?
- Would blocking NPY signaling during acute MI reduce cardiac damage?
Common questions
Why does NPY increase during heart attacks?
Could NPY testing help diagnose heart attacks?
Read the original research
Role of plasma neuropeptide Y in acute myocardial infarction: a case-control study.
BMC cardiovascular disorders, 24(1), 692
Citation
Zheng, Yan-Li; Lin, Hui-Li; Li, Yue-Ting; Li, Mei-Mei; Du, Jing-Ru; Wang, Wan-da; Wang, Yao-Guo; Cai, Yin-Lian. (2024). Role of plasma neuropeptide Y in acute myocardial infarction: a case-control study.. BMC cardiovascular disorders, 24(1), 692. https://doi.org/10.1186/s12872-024-04373-1